Santiago is a PhD candidate in the department of Genetics at Yale University’s School of Medicine. His project in Dr. Stephen Strittmatter’s lab includes investigating the molecular mechanisms underlying the pathophysiology of Alzheimer’s disease. Before coming to Yale, Santiago studied breast cancer and mammary gland development as an undergraduate researcher at the University of California, Santa Cruz. Santiago was also co-founder of Anthos Pharmaceuticals; a Yale startup looking to commercialize a novel Alzheimer’s therapeutic through the NIH Neuro Startup Challenge. Along with his sustained commitment to translational research, Santiago brings to the Yale Canaan partnership his passion for entrepreneurship.